메뉴 건너뛰기




Volumn 69, Issue 11, 2017, Pages 1407-1408

Tolvaptan in Acute Heart Failure: Time to Move On

Author keywords

acute heart failure; decongestion; outcomes; strategies; volume overload

Indexed keywords

DIURETIC AGENT; PLACEBO; TOLVAPTAN; VASOPRESSIN RECEPTOR ANTAGONIST;

EID: 85015157745     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.09.005     Document Type: Editorial
Times cited : (8)

References (10)
  • 1
    • 85015226208 scopus 로고    scopus 로고
    • Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure
    • 1 Felker, G.M., Mentz, R.J., Cole, R.T., et al. Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure. J Am Coll Cardiol 69 (2017), 1399–1406.
    • (2017) J Am Coll Cardiol , vol.69 , pp. 1399-1406
    • Felker, G.M.1    Mentz, R.J.2    Cole, R.T.3
  • 2
    • 84953343125 scopus 로고    scopus 로고
    • Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF trials
    • 2 Felker, G.M., Mentz, R.J., Adams, K.F., et al. Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF trials. Circ Heart Fail 8 (2015), 997–1005.
    • (2015) Circ Heart Fail , vol.8 , pp. 997-1005
    • Felker, G.M.1    Mentz, R.J.2    Adams, K.F.3
  • 3
    • 2142694387 scopus 로고    scopus 로고
    • Vasopressin receptor antagonists: will the “vaptans” fulfill their promise?
    • 3 Francis, G.S., Tang, W.H., Vasopressin receptor antagonists: will the “vaptans” fulfill their promise?. JAMA 291 (2004), 2017–2018.
    • (2004) JAMA , vol.291 , pp. 2017-2018
    • Francis, G.S.1    Tang, W.H.2
  • 4
    • 33947713810 scopus 로고    scopus 로고
    • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial
    • 4 Konstam, M.A., Gheorghiade, M., Burnett, J.C. Jr., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007), 1319–1331.
    • (2007) JAMA , vol.297 , pp. 1319-1331
    • Konstam, M.A.1    Gheorghiade, M.2    Burnett, J.C.3
  • 5
    • 70349464874 scopus 로고    scopus 로고
    • Effects of tolvaptan on dyspnoea relief from the EVEREST trials
    • 5 Pang, P.S., Konstam, M.A., Krasa, H.B., et al. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J 30 (2009), 2233–2240.
    • (2009) Eur Heart J , vol.30 , pp. 2233-2240
    • Pang, P.S.1    Konstam, M.A.2    Krasa, H.B.3
  • 6
    • 79960090547 scopus 로고    scopus 로고
    • Effect of nesiritide in patients with acute decompensated heart failure
    • 6 O'Connor, C.M., Starling, R.C., Hernandez, A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365 (2011), 32–43.
    • (2011) N Engl J Med , vol.365 , pp. 32-43
    • O'Connor, C.M.1    Starling, R.C.2    Hernandez, A.F.3
  • 7
    • 84871986523 scopus 로고    scopus 로고
    • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
    • 7 Teerlink, J.R., Cotter, G., Davison, B.A., et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381 (2013), 29–39.
    • (2013) Lancet , vol.381 , pp. 29-39
    • Teerlink, J.R.1    Cotter, G.2    Davison, B.A.3
  • 9
    • 84879785466 scopus 로고    scopus 로고
    • Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
    • 9 Mentz, R.J., Hernandez, A.F., Stebbins, A., et al. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail 15 (2013), 456–464.
    • (2013) Eur J Heart Fail , vol.15 , pp. 456-464
    • Mentz, R.J.1    Hernandez, A.F.2    Stebbins, A.3
  • 10
    • 79959403043 scopus 로고    scopus 로고
    • Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study
    • 10 Metra, M., O'Connor, C.M., Davison, B.A., et al. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study. Eur Heart J 32 (2011), 1519–1534.
    • (2011) Eur Heart J , vol.32 , pp. 1519-1534
    • Metra, M.1    O'Connor, C.M.2    Davison, B.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.